News & Media

News

​​​​​​​
ImmunOs Therapeutics AG raises CHF 15M in Series A Financing, co-led by Pfizer Ventures and BioMedPartners, to Advance a Novel Immunotherapy Agent For Cancer Into Human Trials 
Read Article

UZH Life Sciences Fund and Schroder Adveq Invest in ImmunOs Therapeutics AG to Support Advancement of their Immunotherapy Platform for Cancer
Read Article​

ImmunOs Therapeutics AG closes 2.3 Million Financing to Support Lead Clinical Candidate Program Acceleration
Read Article

ImmunOs Therapeutics AG appoints Pamela Carroll, Ph.D., a Leading Industry and Academic Oncology Drug Discovery Expert to the Scientific Advisory Board
Read Article

ImmunOs Therapeutics AG Partners with Locust Walk to Support Business Development Activities for their Novel Innate Immunity Targeting Immunotherapy Platform for Cancer

Read Article​

ImmunOs Therapeutics AG appoints Leading U.S. Based Academic and Industry Oncology, Immunology, and Product Development Experts to the Scientific Advisory Board

Read Article                                                                                                                                                                                                                          

ImmunOs Therapeutics AG appoints Sean R. Smith as new Chief Executive Officer and Dr. Osiris Marroquin-Belaunzaran as Chief Scientific Officer Read Article